Abstract
Recent studies point to the importance of small-noncoding RNAs (sRNAs) in bacterial virulence control. In Staphylococcus aureus, functional dissections of sRNAs are limited to RNA III, SprD, RsaE, SprA1, and SSR42 only. Here, we report the identification and functional analyses of a novel sRNA, which we have designated ArtR. Our data show that the AgrA protein can bind to the artR promoter and repress artR transcription, suggesting that, after RNA III, ArtR is the second sRNA regulated by AgrA. Furthermore, ArtR is unique in S. aureus and involved in virulence regulation by activating α-toxin expression. ArtR promotes the degradation of sarT mRNA by RNase III and arrests the translation of SarT by direct binding to the 5′ untranslated region of the sarT mRNA, suggesting that the activation of ArtR on the α-toxin expression was through SarT. This study reveals another kind of staphylococcal regulatory small RNA that plays a role in virulence control. It also indicates the diversity of small RNA-target mRNA interactions and how these multiple interactions can mediate virulence regulation in this pathogen.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Over the past 10 years, small, noncoding RNA (sRNA) encoded on bacterial chromosomes has become very attractive to researchers. Hundreds of candidate sRNA genes in various bacteria have been identified by computational prediction, oligonucleotide microarrays, and deep sequencing [1–5]. Some sRNAs can bind to proteins and then modulate their activity, or act by direct base pairing to their target mRNA. Base pairing between sRNA and target RNA can lead to translation blocking, mRNA translation activation, or specific cleavage of the complex by RNase [6, 7]. Through these mechanisms, sRNA can repress transposition in Salmonella enterica [8] and Listeria monocytogenes [9], regulate the synthesis of some transcription regulators in Escherichia coli [10], and influence some metabolic and virulence factors [11–13]. Recent studies performed on sRNA in some pathogens point to the importance of sRNAs in virulence control [9, 14–18].
Staphylococcus aureus is a human and animal pathogen that can cause multiple diseases, ranging from localized skin infections to life-threatening systemic infections [19, 20]. The high infection ability of S. aureus depends on the production of many virulence factors and regulatory elements, including some transcriptional regulator proteins, two-component systems, and other regulators [21–23]. One of the most important regulators is the Agr/RNA III system. It is a global regulon composed of two divergent transcripts called RNA II and RNA III. The RNA II transcript contains a density-sensing cassette Agr D/B and a two-component system AgrC/A, while RNA III is a multifunctional sRNA and the best characterized sRNA in S. aureus. RNA III regulates the expression of many virulence genes as well as some transcription factors at the post-transcriptional level. Binding between RNA III and its targets (hla, spa, rot, coa) can lead to translation activation, translation blocking, or unstable mRNA [24–27].
Research into RNA III has been conducted for several years, and an increasing focus has been placed on the search for additional sRNAs in S. aureus. Close to one hundred novel sRNAs have been found in S. aureus in recent years by computational or experimental analysis [18, 28–32]. Most of them were predicted based on the search for intergenic regions (IGRs) with a rho-independent terminator, conserved structural motifs, and the absence of open-reading frame (ORF) [28], by which the transcripts encoded in genes or those overlapped by genes will not be found. As experimental approaches have improved, more powerful sRNA detection methods have been developed, including direct labeling, microarrays, and sequencing [30, 31, 33, 34]. Nevertheless, only a few cis-encoded sRNAs have been found because the data analysis was associated with the IGRs [31]. Besides this, although more and more sRNAs have been identified in S. aureus and S. aureus has emerged as a model organism for the study of bacterial sRNA [35], functional studies of these sRNAs are behind and are irregular in their prediction. Detailed functional analysis is limited to RNA III, SprD, RsaE, SprA1, and SSR42 only [29, 36–38].
We show here that a novel sRNA overlapped by luxS was discovered and studied. This sRNA was named ArtR (AgrA-repressed, toxin-regulating sRNA) and found to be repressed by the transcriptional regulator AgrA. Our gel-shift assays showed that AgrA can bind to the promoter region of artR, and RT-PCR confirmed that AgrA can repress artR transcription. The deletion of hfq did not affect artR transcription, and the Hfq protein could not bind to the ArtR transcript in vitro, indicating that Hfq has no influence on the stability or functioning of ArtR. In addition, our results also showed that ArtR is involved in staphylococcal virulence regulation. The deletion of artR led to a decrease in α-toxin, and we further proved that the activation of hla occurred through the transcriptional regulator SarT. Direct binding between ArtR and the sarT transcript was observed, and the binding domain was located at the 5′ UTR region of sarT mRNA. Binding between ArtR and the 5′ UTR of sarT mRNA provides digestion sites for endoribonuclease III (RNase III), promoting the degradation of sarT mRNA and activation of the expression of hla.
Materials and methods
Strains and plasmids
Escherichia coli strains were grown at 37 °C in Luria–Bertani (LB) medium with a suitable antibiotic: ampicillin (100 μg/mL) or kanamycin (50 μg/mL). S. aureus strains were grown at 37 °C in either B-medium (1 % peptone, 0.5 % yeast extract, 0.1 % glucose, 0.5 % NaCl, 0.1 % K2HPO4) or tryptic soy broth (TSB, Oxiod) with a suitable antibiotic: erythromycin (2.5 μg/mL) or chloramphenicol (15 μg/mL), as appropriate. The media were solidified with 1.5 % (wt/vol) agar as needed. Chromosomal DNA from S. aureus was prepared according to the standard procedures for Gram-positive bacteria [39]. Plasmids from E. coli were extracted using a plasmid purification kit (Promega); plasmid extracts from S. aureus cells were pre-digested with a digestion buffer containing 40 U/mL lysostaphin, 10 mg/mL lysozyme, and 10 % (v/v) glycerol. The plasmids were transformed into RN4220 and then NCTC8325 by electroporation, as previously described. The bacterial strains and plasmids used in this study are described in Table 1.
Construction of the mutant and complementing strains
The genes were inactivated using the shuttle plasmid pBT2 as described [40]. Target genes were replaced by the erythromycin-resistant gene (ermB), and all mutants were confirmed by PCR and sequencing. In order to construct the mutant complement, genes with their native promoters were amplified and ligated into the shuttle plasmid pLI50 and transformed into the relevant mutant strains. The primers used in this study are listed in Supplemental Table S1.
RNA isolation, Northern blot analysis, RACE, cDNA generation, and RT-PCR
For RNA extraction, overnight cultures of S. aureus were diluted 1:100 in LB medium and grown to the appropriate phase. RNA was extracted as Wolz et al. [41] described with some modifications. S. aureus cells were pelleted and lysed in 1 mL of RNAiso (TaKaRa) with 0.7 g of zirconia-silica beads (0.1 mm in diameter) in a high-speed homogenizer (IKA® T25 digital UlTRATURRAX®). Residual DNA was degraded by treatment with 10 U of DNaseI (Takara) at 37 °C for 1 h. The 5′ and 3′ ends of ArtR were determined by RACE as described [42], using the 3′-Full RACE Core Set Ver.2.0 and 5′-Full RACE Kit (Takara). Reverse transcription was carried out with the PrimeScript 1st Strand cDNA synthesis kit and real-time PCR was performed with SYBR Premix Ex Taq (TaKaRa) using a StepOne real-time system (Applied Biosystems). The quantity of cDNA was normalized to the abundance of 16S cDNA. For Northern blot analysis, 10 or 50 μg of total RNA was separated in 3.5 % polyacrylamide-7 M urea gel electrophoresis in 1 × TBE and then electrotransferred to a charged nylon membrane (Millipore) in 0.5 × TBE. Biotin-labeled primer probes complementary to ArtR were chemically synthesized (Invitrogen). Hybridization and luminescence detection were performed using the North2South Chemiluminescent Hybridization and Detection Kit (Pierce). The size of the transcripts was estimated by comparing them with RNA molecular standards (Takara).
Western blot of the α-toxin and SarT
Western blot was performed as previously described [43]. For the α-toxin Western blot assay, stationary-phase supernatant was collected and concentrated by 10 kD ultra-filtration (Minipole). After heated for 10 min at 95 °C, the samples were separated by 12 % SDS-PAGE and then electrotransferred onto a polyvinylidene difluoride membrane (GE). The protein was detected by a rabbit anti-α-toxin antibody (Sigma) followed by horseradish peroxidase-conjugated sheep anti-rabbit antibodies (Pierce). For the SarT protein, bacterial cells at early log phase (OD600 = 1.0) was collected and lysed for 30 min at 37 °C by lysostaphin and then heated for 10 min at 95 °C as the sample for electrophoresis. Polyclonal antibody against SarT was acquired from Abgent Biotechnology (SuZhou, China), using peptide “PKWLAVYSEADSSKDHC” as the antigen.
Protein overexpression of AgrA DNA-binding domain, RNase III, and Hfq
The His-tagged AgrA DNA-binding domain was cloned and purified using standard procedures. The fragment of DNA-binding domain of agrA was amplified from S. aureus NCTC8325 genomic DNA, inserted into pET28a (+), and then transformed into E. coli BL21 (DE3). The strain was grown at 37 °C to an OD600 of 0.4; the temperature was reduced to 16 °C, and the cells were induced overnight with 1 mM IPTG. The method for Hfq expression was similar to AgrA. Expression of the RNase III was induced as described [44], and the sequence was cloned into pQE30 and then transformed into E. coli M15 (pREP-4). The strain was incubated at 37 °C for 4 h with 1 mM IPTG. The fusion proteins were purified by Ni–NTA resin, eluted, passed through an ultrafiltration system to remove imidazole, and then stored in 10 % glycerol at −80 °C until use. Protein purity and concentration were determined by SDS-PAGE and the Bradford assay.
RNA preparation and labeling
The RNAs were produced by in vitro transcription as described [27] using a RiboMAX Large Scale RNA Production Systems-T7 (Promega). Full-length labeled RNAs were produced using the Digoxigenin (DIG) RNA labeling Mix (Roche) or Biotin RNA labeling Mix (Roche). End-labeling RNAs were produced using a DIG gel-shift kit (second generation; Roche). The RNAs were purified from 6 % denaturing polyacrylamide gels and stored at −80 °C until use.
Gel-shift assay
The gel-shift assay between AgrA and the promoter DNA was performed as previously described [45–47]. The artR promoter was amplified from NCTC8325 genomic DNA and labeled with DIG by using a DIG gel-shift kit (Roche). The binding reaction was performed by incubating the labeled probe with increasing amounts of AgrA at 25 °C for 20 min. After incubation, the mixtures were electrophoresed in 4 % native polyacrylamide gel in a 0.5 × TBE buffer. The band shifts were detected and analyzed according to the manufacturer’s instructions.
Determination of the ArtR complex with its target mRNAs
Gel-shift assays between ArtR and the mRNAs were performed as described [27]. The binding reactions were performed by mixing the labeled ArtR with increasing amounts of the target mRNAs (RNA III, hla, sarT, sarT 5′ UTR, sarT CDS, and sarT 3′ UTR) in TMN buffer (20 mM Tris–acetate at pH 7.5, 10 mM magnesium acetate, 150 mM sodium acetate, 1 mM DTT). The mixture was then denatured at 85 °C for 2 min, followed by refolding at 37 °C for 10 min. The mixture was added to RNA loading buffer and electrophoresed in 4 % native PAGE in 1 × TBE, electrotransferred and detected according to the manufacturer’s instructions.
Cleavage assays of the RNA complex by RNase III
Cleavage of labeled RNA was performed as previously described [25, 44]. The DIG-labeled free RNA or the RNA–RNA complex was mixed in Tris-NaCl buffer (pH 8.5) containing 100 mM MgCl2. Cleavage was carried out at 37 °C for 30 min with 2 pmol RNase III, and then the mixtures were added to RNA loading buffer, electrophoresed in 4 % native PAGE in 1 × TBE, electrotransferred and detected according to the manufacturer’s instructions.
Statistical analysis
All quantitative data were analyzed using Student’s t tests. P < 0.05 was considered to be statistically significant.
Results
Identification of artR locus
The discovery of ArtR is from our previous study on the function of luxS in S. aureus [45]. We found that deletion of the whole coding sequence of luxS led to the decrease in hla expression. However, the complementing plasmid of luxS can not restore the phenotype. Therefore, we constructed a series of complementing plasmids (Fig. 1a) and found that the sequence that was overlapped with the 3′ region of luxS can restore the phenotype (Fig. 1b), suggesting that a hypothetical functional gene may exist in the region. By RT-PCR, Northern blot, and RACE analysis, we determined the existence and the coding sequence of ArtR. In addition, we constructed the luxS single mutant, in which a 15-bp sequence in the luxS 5′ region was only deleted as shown in Fig. 1c. The transcription of hla in this mutant did not change (Fig. 1d), suggesting that ArtR, not LuxS, is the regulator of hla.
Northern blot, RACE, and bioinformatic analyses of ArtR
The existence of the artR gene was first verified in the S. aureus NCTC8325 by RT-PCR. In order to determine the 5′ and 3′ ends of artR, we performed primer extension and rapid amplification of the cDNA ends (RACE) analysis to confirm the full transcript of ArtR. Sequencing analysis indicated that the artR gene contains a 345-bp-long sequence located between the luxS gene and SAOHSC_02376, flanked by two ORFs (Fig. 2a). Furthermore, we confirmed the existence and length of ArtR by performing the Northern blot assays (Fig. 2b). Hence, an alignment was run between the closely related sequences in several S. aureus strains and the Staphylococcus epidermidis strain rp62a. As shown in Fig. S1, the 3′ region of artR, which overlapped with the luxS gene, was highly conserved in all strains, whereas the sequence in the 5′ region of artR and in the intergenic region was only conserved in S. aureus strains. Because the 5′ region is involved in transcription initiation, this alignment made us wonder whether or not the ArtR transcript exists in S. epidermidis. Therefore, RT-PCR was designed and performed on these eight strains according to our RACE results, and the length of the PCR products was 330-bp long in the 345-bp ArtR-coding gene. As shown in Fig. 1c, the ArtR transcript was amplified in all S. aureus strains that we selected, but not in S. epidermidis rp62a. Considering that the artR-coding sequence in S. epidermidis is most closely related to that in S. aureus compared to the other Gram-positive strains, we conclude that ArtR might be a unique sRNA that only exists in S. aureus. In addition, we performed RT-PCR assays to test the transcription of artR in these staphylococcal strains, and our results showed that the transcript levels of artR in these strains were similar (Fig. S2).
AgrA can repress the transcription of artR
The Agr system is autoinduced by an extracellular ligand, AIP, which represents a sensor of population density. Activation of the sensor protein AgrC results in the phosphorylation of AgrA, the response regulator, which then binds to the agr promoter to initiate RNA II and RNA III transcription [48]. Since the Agr system in S. aureus NCTC8325 is generally acknowledged to be indispensable for the regulation of a great amount of genes, we performed RT-PCR assays to measure artR transcription in this strain and its agr mutant. As shown in Fig. 3a, the artR transcription level of the agr mutant was always higher than that of the wild type, indicating that Agr might be a repressor of artR. Because RNA III is the main effector molecule of the Agr system, we initially speculated that RNA III might regulate artR transcription. However, our RT-PCR results showed that inactivation of RNA III did not influence artR transcription (Fig. 3b). We also transcribed RNA III and ArtR in vitro and performed RNA–RNA gel-shift assays between them. As shown in Fig. 3c, RNA III easily bound to the 5′ UTR region of hla mRNA and this result was consistent with previous work [24]. However, we did not observe the formation of the RNA III–ArtR complex at all. With these in mind, we concluded that the Agr system repressed artR transcription through a RNA III-independent pathway. Previous study verified that purified AgrA shows high-affinity binding to the RNA III-agrCDAB intergenic region [46]. By DNase I protection assays, they determined the specific binding sequences of AgrA in the P2 and P3 promoter regions of the agr locus (Fig. 3d). And, as shown in Fig. 3e, we also found a highly conserved AgrA-binding site that was near the −35 region of the artR promoter. According to this, we over-expressed the DNA-binding domain of the AgrA protein and performed gel-shift assays. The results confirmed that AgrA also exhibited high-affinity binding to the artR promoter (Fig. 3f), demonstrating that the Agr system represses artR transcription through AgrA, but not RNA III.
ArtR activates α-toxin expression through an indirect pathway
Previous studies have indicated that sRNA can mediate virulence regulation in some pathogens [18], and our results also showed that ArtR might be involved in the regulation of the α-toxin expression. As shown in Fig. 4a, the transcript level of hla in the artR mutant decreased 60 % compare with that in the wild type when the bacteria grew to the post-exponential phase. We also measured the transcription of hla in a different growth phase in these strains and the results were consistent with the above data. Western blot assays showed that, when the growth of the cells became stationary, the expression of α-toxin also decreased in the artR mutant (Fig. 4b), further demonstrating that ArtR is an activator of the α-toxin expression. According to previous studies, ArtR might regulate hla expression through two possible pathways: a direct interaction with hla mRNA or an indirect interaction through some intermediates. By using bioinformatics methods, we aligned the sequences of ArtR and hla mRNA and tried to explore whether or not ArtR could bind to hla mRNA as RNA III does. According to the alignments, there are several possible binding sites with low energy in the 5′ UTR region of hla mRNA. Therefore, we performed the RNA–RNA binding experiment between ArtR and the 5′ UTR of hla mRNA and the hla full-length mRNA. As shown in Fig. 4c, no binding complex was observed between ArtR and hla mRNA or its 5′ UTR, suggesting that ArtR may activate the hla transcription through an indirect pathway.
ArtR can activate hla expression through sarT by direct binding to sarT mRNA
Since there are many regulators that can modulate hla expression, we measured the transcript levels of the regulators agrA, sarA, sae, rot, arl, clpP, and sarT [49–52] by RT-PCR. Our results showed that only the transcription of sarT was changed in the artR mutant compared to that of the wild type. As shown in Fig. 5a, the transcript level of sarT was 1.85-fold higher in the artR mutant than that in the wild type. Moreover, we compared the protein levels of SarT in the artR mutant and the wild type by Western blot assays. The results confirmed that the SarT expression level is higher in artR mutant than that in the wild type (Fig. 5b), indicating that SarT might be the mediator linking ArtR regulation to hla expression. According to the alignments, we assumed that there is a 40-nt-long possible binding site of ArtR with low energy in the 5′ UTR region of sarT mRNA (Fig. 5c). Therefore, we carried out RNA–RNA gel-shift assay between ArtR and the sarT mRNA or the different parts of the sarT mRNA (5′ UTR, CDS, and 3′ UTR) to investigate whether ArtR directly regulates sarT or not. The luxS mRNA was chosen for the positive control because there is perfect pairing between luxS and artR. As shown in Fig. 5d, the sarT mRNA or the 5′ UTR of sarT mRNA can bind to ArtR, suggesting that ArtR may affect the stability of the sarT mRNA through a direct interaction. By using the mutational sarT mRNA (sarT mRNA with 40-nt-long binding sequence deletion) as the negative control, we further confirmed that the 40-nt-long binding sequence in the 5′ UTR of sarT mRNA is essential for the interaction of ArtR with sarT mRNA (Fig. S3).
ArtR promotes the degradation of sarT mRNA by RNase III
As declared before, RNase III contributes a lot to the regulation of sRNA in S. aureus [25–27, 53]; thus, we also investigated the influence of RNase III on ArtR-sarT regulation. To provide the direct evidence that RNase III is involved in sarT regulation by ArtR, a digestion experiment was carried out. As shown in Fig. 6, with the increasing addition of ArtR, a greater digestion of the sarT 5′ UTR was observed. These results indicate that ArtR can form a stable complex with the 5′ UTR of sarT mRNA and decrease the level of sarT mRNA through RNase III-mediated degradation.
Hfq does not bind to ArtR in vitro and is not involved in the stability of ArtR
According to previous studies, Hfq is an RNA binding protein that interacts with both sRNAs and mRNAs to post-transcriptionally modulate gene expression. In E. coli, Hfq can affect the stability of several sRNAs and mRNAs [54] and target them for degradation by increasing polyadenylation [55, 56] or interfering with ribosome binding and translation [57]. In S. aureus, whether or not Hfq can function as a sRNA chaperone still remains disputable. In order to answer this question, we constructed the hfq mutant and measured the transcript level of artR by RT-PCR. As shown in Fig. S4A, the transcript level of artR in the hfq mutant was similar to that in the wild type throughout the whole growth phase. Our protein-RNA gel-shift assays also confirmed that Hfq could not bind to the ArtR transcript in vitro (Fig. S4B). These data indicate that Hfq does not interact with ArtR or affect its stability. In addition, we measured the transcript levels of sarT and hla, which might be the target mRNAs of ArtR. The results showed that the inactivation of hfq did not affect the transcription of the two genes either (Fig. S5), indicating that Hfq might not be required for ArtR-dependent regulation.
Discussion
In recent years, an increasing amount of research has focused on bacterial sRNAs, which are emerging as regulators that enable bacterial pathogens to express virulence factors when required during infection. Roles of numerous sRNAs in the pathogenesis have been identified in many Gram-positive and Gram-negative bacteria. However, the progress of sRNA research in S. aureus is relatively slow. A detailed functional analysis has only been performed for four sRNAs: RNA III, SprD, SprA1, and RsaE. In this work, we identified a novel sRNA, ArtR. The 5′ end of artR sequence is overlapped with the 3′ end of the SAOUSHC_02376 gene, and 153 bp of the 3′ end is overlapped with the 3′ end of luxS, while the rest is located in the intergenic regions between SAOUSHC_02376 and luxS. Because of the limitations in the methodology, this kind of genetic constitution of sRNA has not been recognized before in S. aureus. Besides this, bioinformatic analysis indicated that the coding sequence of ArtR is extremely conserved among S. aureus. RT-PCR data showed that there were obvious ArtR transcripts in seven S. aureus strains (Fig. 2c), whereas no ArtR transcript was observed in S. epidermidis. Furthermore, considering that the virulence factor α-toxin, which is regulated by ArtR, does not exist in S. epidermidis, we suggest that ArtR might be a virulence-associated regulatory sRNA particular to S. aureus.
In S. aureus, RNA III is the model of RNA-controlled virulence gene expression, being the effector of the Agr system. When bacteria grow to the post-exponential phase, phosphorylation-activated AgrA can bind to the promoter region of RNA III and activate its transcription. A previous study reported that phenol-soluble modulins expression was regulated by direct binding of the AgrA, suggesting that AgrA may play a more important role in virulence regulation by binding to other potential targets except RNA III [58]. Interestingly, we found that there is also a highly conserved AgrA-binding box in the promoter region of artR by sequence alignment. Our gel-shift data confirmed the high-affinity binding of AgrA to the promoter region of artR. Apart from that, the RT-PCR data showed that inactivation of Agr resulted in an apparent increase in the transcript level of artR. These results suggest that, after RNA III, ArtR is the second sRNA that can be regulated by the transcriptional regulator AgrA. However, unlike RNA III, AgrA always repressed the transcription of artR regardless of any bacterial growth phase under our experimental conditions (Fig. 3a). We also performed gel-shift experiments by adding acetyl phosphate to AgrA, and the results indicated that exogenous acetyl phosphate did not influence the binding ability of AgrA to the artR promoter (data not shown). Moreover, as shown in Fig. 3e, the binding box of AgrA on the artR promoter is adjacent to the −35 region, suggesting that this binding may cause the interference of transcription initiation.
As a SarA homolog, the transcriptional regulator SarT can repress hla expression [51], and this gene exists in S. aureus strains COL, RN6390, Newman, and DB and S. saprophyticus, but not in S. epidermidis or S. haemolyticus [59]. Our gel-shift assays indicated that the SarT protein exhibits high-affinity binding to the hla promoter region in vitro (Fig. S6). In this study, we show that ArtR can repress α-toxin expression by binding to the sarT mRNA and promoting its degradation. The regulatory behavior of ArtR on SarT is very similar to that of RNA III on Rot [26, 60], suggesting that the regulation of the transcription factor by regulatory sRNAs via an antisense mechanism is ubiquitous in bacteria. In addition, as reported before, the regulation by sRNA may enable fine-tuning of target gene expression level [61, 62], implying that in a complex regulatory network, the influence of the sRNA on target gene expression may be limited.
The Hfq protein has generally been recognized as the small RNA chaperone in Gram-negative bacteria. The Hfq protein of E. coli has been directly linked to the action of several small regulatory RNAs that use base pairing to regulate the expression of target mRNAs [63, 64]. In S. aureus, whether or not Sm-like Hfq can function as a small RNA chaperone still remains unknown. In a previous study using gel-shift experiments, S. aureus Hfq was shown to bind to RNA III with a higher affinity than the regulatory region of the spa mRNA. However, the addition of increasing concentrations of Hfq had no significant effect on the formation of the RNA III-spa mRNA complex [25]. Despite the fact that Hfq binds to RNA III, the observation that the deletion of hfq does not exhibit severe phenotypic defects rules out the possibility of direct involvement of Hfq in regard to RNA III-mediated regulation in S. aureus [25]. Another previous work reported that SprA1 steady-state levels were unaffected by the presence or absence of Hfq in vivo, suggesting that the protein is dispensable for the interaction between SprA1AS and SprA1 [37]. Our study showed that the inactivation of hfq did not affect the stability of ArtR (Fig. S4) or the transcription of sarT and hla (Fig. S5). The RNA–RNA gel-shift experiments also showed no binding effects between Hfq and ArtR. These findings led us to suggest that the S. aureus Hfq protein may not be required for small RNA-dependent regulation.
References
Sittka A, Lucchini S, Papenfort K, Sharma CM, Rolle K, Binnewies TT, Hinton JCD, Vogel J (2008) Deep sequencing analysis of small noncoding RNA and mRNA targets of the global post-transcriptional regulator, Hfq. Plos Genet 4(8). doi:10.1371/journal.pgen.1000163
Thomason MK, Storz G (2010) Bacterial antisense RNAs: how many are there, and what are they doing? Annu Rev Genet 44:167–188. doi:10.1146/annurev-genet-102209-163523
Storz G, Waters LS (2009) Regulatory RNAs in bacteria. Cell 136(4):615–628. doi:10.1016/j.cell.2009.01.043
Altuvia S (2007) Identification of bacterial small non-coding RNAs: experimental approaches. Curr Opin Microbiol 10(3):257–261. doi:10.1016/j.mib.2007.05.003
Livny J, Teonadi H, Livny M, Waldor MK (2008) High-throughput, kingdom-wide prediction and annotation of bacterial non-coding RNAs. Plos One 3(9). doi:10.1371/Journal.Pone.0003197
Thomason MK, Storz G (2010) Bacterial antisense RNAs: how many are there, and what are they doing? Annu Rev Genet 44:167–188. doi:10.1146/annurev-genet-102209-163523
Liu MY, Gui GJ, Wei BD, Preston JF, Oakford L, Yuksel U, Giedroc DP, Romeo T (1997) The RNA molecule CsrB binds to the global regulatory protein CsrA and antagonizes its activity in Escherichia coli. J Biol Chem 272(28):17502–17510
Altuvia S, Padalon-Brauch G, Hershberg R, Elgrably-Weiss M, Baruch K, Rosenshine I, Margalit H (2008) Small RNAs encoded within genetic islands of Salmonella typhimurium show host-induced expression and role in virulence. Nucleic Acids Res 36(6):1913–1927. doi:10.1093/nar/gkn050
Toledo-Arana A, Dussurget O, Nikitas G, Sesto N, Guet-Revillet H, Balestrino D, Loh E, Gripenland J, Tiensuu T, Vaitkevicius K, Barthelemy M, Vergassola M, Nahori MA, Soubigou G, Regnault B, Coppee JY, Lecuit M, Johansson J, Cossart P (2009) The Listeria transcriptional landscape from saprophytism to virulence. Nature 459(7249):950–956. doi:10.1038/nature08080
Opdyke JA, Kang JG, Storz G (2004) GadY, a small-RNA regulator of acid response genes in Escherichia coli. J Bacteriol 186(20):6698–6705. doi:10.1128/Jb.186.20.6698-6705.2004
Duhring U, Axmann IM, Hess WR, Wilde A (2006) An internal antisense RNA regulates expression of the photosynthesis gene isiA. Proc Natl Acad Sci USA 103(18):7054–7058. doi:10.1073/pnas.0600927103
Andre G, Even S, Putzer H, Burguiere P, Croux C, Danchin A, Martin-Verstraete I, Soutourina O (2008) S-box and T-box riboswitches and antisense RNA control a sulfur metabolic operon of Clostridium acetobutylicum. Nucleic Acids Res 36(18):5955–5969. doi:10.1093/Nar/Gkn601
Lee EJ, Groisman EA (2010) An antisense RNA that governs the expression kinetics of a multifunctional virulence gene. Mol Microbiol 76(4):1020–1033. doi:10.1111/j.1365-2958.2010.07161.x
Vogel J, Papenfort K (2010) Regulatory RNA in bacterial pathogens. Cell Host Microbe 8(1):116–127. doi:10.1016/j.chom.2010.06.008
Vogel J, Sharma CM, Hoffmann S, Darfeuille F, Reignier J, Findeiss S, Sittka A, Chabas S, Reiche K, Hackermuller J, Reinhardt R, Stadler PF (2010) The primary transcriptome of the major human pathogen Helicobacter pylori. Nature 464(7286):250–255. doi:10.1038/nature08756
Wai SN, Song T, Mika F, Lindmark B, Liu Z, Schild S, Bishop A, Zhu J, Camilli A, Johansson J, Vogel J (2008) A new Vibrio cholerae sRNA modulates colonization and affects release of outer membrane vesicles. Mol Microbiol 70(1):100–111. doi:10.1111/j.1365-2958.2008.06392.x
Gripenland J, Netterling S, Loh E, Tiensuu T, Toledo-Arana A, Johansson J (2010) RNAs: regulators of bacterial virulence. Nat Rev Microbiol 8(12):857–866. doi:10.1038/nrmicro2457
Henkin TM (2008) Riboswitch RNAs: using RNA to sense cellular metabolism. Genes Dev 22(24):3383–3390. doi:10.1101/gad.1747308
Blot S, Vandewoude K, Colardyn F (1998) Staphylococcus aureus infections. N Engl J Med 339 (27):2025–2026 (author reply 2026–2027)
Abrahamian FM, Moran GJ (2007) Methicillin-resistant Staphylococcus aureus infections. N Engl J Med 357(20):2090. doi:10.1056/NEJMc072407 (author reply 2090)
Cheung AL, Bayer AS, Zhang G, Gresham H, Xiong YQ (2004) Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol Med Microbiol 40(1):1–9
Bronner S, Monteil H, Prevost G (2004) Regulation of virulence determinants in Staphylococcus aureus: complexity and applications. FEMS Microbiol Rev 28(2):183–200. doi:10.1016/j.femsre.2003.09.003
Novick RP (2003) Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48(6):1429–1449
Morfeldt E, Taylor D, von Gabain A, Arvidson S (1995) Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. EMBO J 14(18):4569–4577
Huntzinger E, Boisset S, Saveanu C, Benito Y, Geissmann T, Namane A, Lina G, Etienne J, Ehresmann B, Ehresmann C, Jacquier A, Vandenesch F, Romby P (2005) Staphylococcus aureus RNAIII and the endoribonuclease III coordinately regulate spa gene expression. EMBO J 24(4):824–835. doi:10.1038/sj.emboj.7600572
Boisset S, Geissmann T, Huntzinger E, Fechter P, Bendridi N, Possedko M, Chevalier C, Helfer AC, Benito Y, Jacquier A, Gaspin C, Vandenesch F, Romby P (2007) Staphylococcus aureus RNAIII coordinately represses the synthesis of virulence factors and the transcription regulator Rot by an antisense mechanism. Genes Dev 21(11):1353–1366. doi:10.1101/gad.423507
Chevalier C, Boisset S, Romilly C, Masquida B, Fechter P, Geissmann T, Vandenesch F, Romby P (2010) Staphylococcus aureus RNAIII binds to two distant regions of coa mRNA to arrest translation and promote mRNA degradation. PLoS Pathog 6(3):e1000809. doi:10.1371/journal.ppat.1000809
Pichon C, Felden B (2005) Small RNA genes expressed from Staphylococcus aureus genomic and pathogenicity islands with specific expression among pathogenic strains (vol 102, p 14249, 2005). Proc Nat Acad Sci USA 102(46):16905–16905. doi:10.1073/pnas.0503838102
Geissmann T, Chevalier C, Cros MJ, Boisset S, Fechter P, Noirot C, Schrenzel J, Francois P, Vandenesch F, Gaspin C, Romby P (2009) A search for small noncoding RNAs in Staphylococcus aureus reveals a conserved sequence motif for regulation. Nucleic Acids Res. doi:10.1093/nar/gkp668
Abu-Qatouseh LF, Chinni SV, Seggewiss J, Proctor RA, Brosius J, Rozhdestvensky TS, Peters G, von Eiff C, Becker K (2010) Identification of differentially expressed small non-protein-coding RNAs in Staphylococcus aureus displaying both the normal and the small-colony variant phenotype. J Mol Med 88(6):565–575. doi:10.1007/s00109-010-0597-2
Bohn C, Rigoulay C, Chabelskaya S, Sharma CM, Marchais A, Skorski P, Borezee-Durant E, Barbet R, Jacquet E, Jacq A, Gautheret D, Felden B, Vogel J, Bouloc P (2010) Experimental discovery of small RNAs in Staphylococcus aureus reveals a riboregulator of central metabolism. Nucleic Acids Res 38(19):6620–6636. doi:10.1093/Nar/Gkq462
Beaume M, Hernandez D, Farinelli L, Deluen C, Linder P, Gaspin C, Romby P, Schrenzel J, Francois P (2010) Cartography of methicillin-resistant S. aureus transcripts: detection, orientation and temporal expression during growth phase and stress conditions. PLoS ONE 5(5):e10725. doi:10.1371/journal.pone.0010725
Vogel J, Sharma CM (2009) Experimental approaches for the discovery anal characterization of regulatory small RNA. Curr Opin Microbiol 12(5):536–546. doi:10.1016/j.mib.2009.07.006
Beaume M, Hernandez D, Francois P, Schrenzel J (2010) New approaches for functional genomic studies in staphylococci. Int J Med Microbiol 300(2–3):88–97. doi:10.1016/j.ijmm.2009.11.001
Anderson KL, Dunman PM (2009) Messenger RNA turnover processes in Escherichia coli, Bacillus subtilis, and emerging studies in Staphylococcus aureus. Int J Microbiol 2009:525491. doi:10.1155/2009/525491
Chabelskaya S, Gaillot O, Felden B (2010) A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immune-evasion molecule. Plos Pathog 6(6). doi:10.1371/journal.ppat.1000927
Sayed N, Jousselin A, Felden B (2012) A cis-antisense RNA acts in trans in Staphylococcus aureus to control translation of a human cytolytic peptide. Nat Struct Mol Biol 19(1):105–112. doi:10.1038/nsmb.2193
Morrison JM, Miller EW, Benson MA, Alonzo F, Yoong P, Torres VJ, Hinrichs SH, Dunman PM (2012) Characterization of SSR42, a novel virulence factor regulatory RNA that contributes to the pathogenesis of a Staphylococcus aureus USA300 representative. J Bacteriol 194(11):2924–2938. doi:10.1128/Jb.06708-11
Novick RP (1991) Genetic systems in staphylococci. Methods Enzymol 204:587–636
Bruckner R (1997) Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. FEMS Microbiol Lett 151(1):1–8
Wolz C, Goerke C, Landmann R, Zimmerli W, Fluckiger U (2002) Transcription of clumping factor A in attached and unattached Staphylococcus aureus in vitro and during device-related infection. Infect Immun 70(6):2758–2762. doi:10.1128/Iai.70.6.2758-2762.2002
Argaman L, Hershberg R, Vogel J, Bejerano G, Wagner EGH, Margalit H, Altuvia S (2001) Novel small RNA-encoding genes in the intergenic regions of Escherichia coli. Curr Biol 11(12):941–950
Fournier B, Klier A, Rapoport G (2001) The two-component system ArlS–ArlR is a regulator of virulence gene expression in Staphylococcus aureus. Mol Microbiol 41(1):247–261
Chevalier C, Huntzinger E, Fechter P, Boisset S, Vandenesch F, Romby P, Geissmann T (2008) Staphylococcus aureus endoribonuclease III purification and properties. Methods Enzymol 447:309–327. doi:10.1016/S0076-6879(08)02216-7
Zhao L, Xue T, Shang F, Sun H, Sun B (2010) Staphylococcus aureus AI-2 quorum sensing associates with the KdpDE two-component system to regulate capsular polysaccharide synthesis and virulence. Infect Immun 78(8):3506–3515. doi:10.1128/IAI.00131-10
Koenig RL, Ray JL, Maleki SJ, Smeltzer MS, Hurlburt BK (2004) Staphylococcus aureus AgrA binding to the RNAIII-agr regulatory region. J Bacteriol 186(22):7549–7555. doi:10.1128/JB.186.22.7549-7555.2004
Wakeman CA, Ramesh A, Winkler WC (2009) Multiple metal-binding cores are required for metalloregulation by M-box riboswitch RNAs. J Mol Biol 392(3):723–735. doi:10.1016/j.jmb.2009.07.033
Novick RP, Projan SJ, Kornblum J, Ross HF, Ji G, Kreiswirth B, Vandenesch F, Moghazeh S (1995) The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol Gen Genet 248(4):446–458
Li D, Cheung A (2008) Repression of hla by rot is dependent on sae in Staphylococcus aureus. Infect Immun 76(3):1068–1075. doi:10.1128/IAI.01069-07
Xiong YQ, Willard J, Yeaman MR, Cheung AL, Bayer AS (2006) Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J Infect Dis 194(9):1267–1275. doi:10.1086/508210
Cluzel ME, Zanella-Cleon I, Cozzone AJ, Futterer K, Duclos B, Molle V (2010) The Staphylococcus aureus autoinducer-2 synthase LuxS is regulated by Ser/Thr phosphorylation. J Bacteriol 192(23):6295–6301. doi:10.1128/JB.00853-10
Frees D, Qazi SN, Hill PJ, Ingmer H (2003) Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance and virulence. Mol Microbiol 48(6):1565–1578
Ji X (2008) The mechanism of RNase III action: how dicer dices. Curr Top Microbiol Immunol 320:99–116
Tsui HC, Feng G, Winkler ME (1997) Negative regulation of mutS and mutH repair gene expression by the Hfq and RpoS global regulators of Escherichia coli K-12. J Bacteriol 179(23):7476–7487
Hajnsdorf E, Regnier P (2000) Host factor Hfq of Escherichia coli stimulates elongation of poly(A) tails by poly(A) polymerase I. Proc Natl Acad Sci USA 97(4):1501–1505. doi:10.1073/pnas.040549897
Le Derout J, Folichon M, Briani F, Deho G, Regnier P, Hajnsdorf E (2003) Hfq affects the length and the frequency of short oligo(A) tails at the 3′ end of Escherichia coli rpsO mRNAs. Nucleic Acids Res 31(14):4017–4023
Vytvytska O, Moll I, Kaberdin VR, von Gabain A, Blasi U (2000) Hfq (HF1) stimulates ompA mRNA decay by interfering with ribosome binding. Genes Dev 14(9):1109–1118
Queck SY, Jameson-Lee M, Villaruz AE, Bach TH, Khan BA, Sturdevant DE, Ricklefs SM, Li M, Otto M (2008) RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol Cell 32(1):150–158. doi:10.1016/j.molcel.2008.08.005
Schmidt KA, Manna AC, Gill S, Cheung AL (2001) SarT, a repressor of alpha-hemolysin in Staphylococcus aureus. Infect Immun 69(8):4749–4758. doi:10.1128/IAI.69.8.4749-4758.2001
Geisinger E, Adhikari RP, Jin R, Ross HF, Novick RP (2006) Inhibition of rot translation by RNAIII, a key feature of agr function. Mol Microbiol 61(4):1038–1048. doi:10.1111/j.1365-2958.2006.05292.x
Shimoni Y, Friedlander G, Hetzroni G, Niv G, Altuvia S, Biham O, Margalit H (2007) Regulation of gene expression by small non-coding RNAs: a quantitative view. Mol Syst Biol 3. doi:10.1038/Msb4100181
Wassarman KM (2002) Small RNAs in bacteria: diverse regulators of gene expression in response to environmental changes. Cell 109(2):141–144
Zhang AX, Wassarman KM, Rosenow C, Tjaden BC, Storz G, Gottesman S (2003) Global analysis of small RNA and mRNA targets of Hfq. Mol Microbiol 50(4):1111–1124. doi:10.1046/j.1365-2958.2003.03734.x
Zhang A, Wassarman KM, Ortega J, Steven AC, Storz G (2002) The Sm-like Hfq protein increases OxyS RNA interaction with target mRNAs. Mol Cell 9(1):11–22
Doherty N, Holden MT, Qazi SN, Williams P, Winzer K (2006) Functional analysis of luxS in Staphylococcus aureus reveals a role in metabolism but not quorum sensing. J Bacteriol 188(8):2885–2897
Xue T, You Y, Hong D, Sun H, Sun B (2011) The Staphylococcus aureus KdpDE two-component system couples extracellular K + sensing and Agr signaling to infection programming. Infect Immun 79(6):2154–2167. doi:10.1128/IAI.01180-10
Acknowledgments
We thank the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for providing the bacterial strains. This work was supported by the National Natural Science Foundation of China (31200107, 31021061).
Author information
Authors and Affiliations
Corresponding author
Additional information
Ting Xue and Xu Zhang have contributed equally to this study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Xue, T., Zhang, X., Sun, H. et al. ArtR, a novel sRNA of Staphylococcus aureus, regulates α-toxin expression by targeting the 5′ UTR of sarT mRNA. Med Microbiol Immunol 203, 1–12 (2014). https://doi.org/10.1007/s00430-013-0307-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00430-013-0307-0